Oncology Outsourced: An Emerging Research Model

Sean Preci
Published on
August 15, 2013

In spite of advances in biology and medicine, cancer remains a major unmet clinical need. In the pharmaceutical and biotechnology worlds, cancer research is focused primarily on diagnostic tool development and target-based drug discovery.

Take the Next Step

1
2
3

Explore Suppliers

Browse trusted partners with relevant expertise

Review Capabilities

Compare services, experience, and past work

Start Your Project

Connect and begin collaborating

Browse Suppliers
​
Post a Project
​
How It Works
​
Written by
Sean Preci
Share this post

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

Read Futher

​
Blog

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Read blog
​
Blog

Industry Insights: Behind the Scenes of BPS Bioscience Custom R&D

Read blog
​
Blog

Making Sustainability More "Sustainable": Driving Transformation at Scale within Biopharma

Read blog
​
Blog

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Read blog
​
Blog

Advanced Screening Strategies for Molecular Glue Discovery

Read blog
​
Blog

Why Large CROs and CDMOs Should Embrace Research Orchestration Platforms - Even with Existing Pharma Clients

Read blog
​
Blog

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Read blog
​
Blog

Supplier Spotlight: RadMD Imaging

Read blog
​
Blog

INsights & OUTcomes with Mark Larkin

Read blog
​
Blog

AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.

Read blog
​
Blog

The Science of the "Gut Feeling": Why Techs are a Lab's Best Diagnostic Tool

Read blog
​
Blog

Supplier Spotlight: MedChemExpress

Read blog
​
Blog

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

Read blog
​
Blog

2026 PharmDev Roadmap: The Regulatory Shift

Read blog
​
Blog

INsights & OUTcomes with Radek Wasiak

Read blog
​
Blog

Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models

Read blog
​
Blog

From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters

Read blog
​
Blog

2026 PharmDev Roadmap: The Strategic Partner

Read blog
​
Blog

2026 PharmDev Roadmap: The Predictive Model

Read blog
​
Blog

INsights & OUTcomes with Taylor Hirschberg

Read blog
​
Blog

2026 PharmDev Roadmap: The Complexity Spike

Read blog
​
Blog

Explore FUJIFILM's Cyclic Peptide Discovery Service

Read blog
​
Blog

2026 PharmDev Roadmap: The Resilience Pivot

Read blog
​
Blog

The Biosecure Act: Navigating Changes in the Biopharma Supply Chain

Read blog
​
Blog

Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology

Read blog
​
Blog

Supplier Spotlight: Shuimu Biosciences

Read blog
​
Blog

2025 Year in Review

Read blog
​
Blog

Beyond the Bead: 10 Questions on How to Improve the Reliability of Flow Cytometry Controls with Precision-Engineered Cell Mimics

Read blog
​
Blog

Your Guide to Chemistry, Manufacturing, and Controls (CMC) Events in 2026

Read blog
​
Blog

Must-Attend Biotech and Pharma Conferences of 2026

Read blog

Read Further

​
blog

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Read blog
​
blog

INsights & OUTcomes with Mark Larkin

Read blog
​
blog

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Read blog
​
blog

Streamlining Supplier Onsite Pre-Assessments: Insights From an Independent Auditor

Read blog
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo